Literature DB >> 11054659

Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression.

M G Diodoro1, E Di Carlo, R Zappacosta, M Iezzi, A Coletti, A Modesti, T D'Antuono, G Forni, P Musiani.   

Abstract

Morphologic examinations of salivary gland neoplasias arising in male BALB/c (H-2d) mice carrying the activated HER-2/neu (BALB-NeuT) indicate that expression of the oncogene product in the ductal-acinar structures results in a very human-like acinic cell adenocarcinoma with a smoldering course and infrequent metastatization. Typical and then atypical hyperplasia of ducts and acini preceded the rise of salivary tumors that originated from the confluence of multiple ductal hyperplastic foci, while hyperplastic acini behaved as an abortive preneoplastic lesion. The vascular network in normal, hyperplastic and neoplastic salivary tissue was analysed to see whether activation of the angiogenic process is essential in salivary gland carcinogenesis. Immunostaining with anti-endothelial cells (anti-CD31), anti-beta3 integrin and anti-laminin antibodies revealed that microvessel density was significantly higher in normal and hyperplastic than in neoplastic tissue, in which no signs of new vessel sprouting were found. Assessment of angiogenic factor expression indicates a low presence of VEGF in normal, hyperplastic and neoplastic epithelium, while bFGF was preferentially produced but not exported by neoplastic cells and remained in a cell-associated form. Our data suggest that normal salivary gland vascularization is able to support tumor onset and development with no need for an angiogenic switch.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054659

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy.

Authors:  Heather M Gibson; Brooke N McKnight; Agnes Malysa; Greg Dyson; Wendy N Wiesend; Claire E McCarthy; Joyce Reyes; Wei-Zen Wei; Nerissa T Viola-Villegas
Journal:  Cancer Res       Date:  2018-08-16       Impact factor: 12.701

2.  FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.

Authors:  Yasuhiro Isono; Mitsuko Furuya; Tatsu Kuwahara; Daisuke Sano; Kae Suzuki; Ryosuke Jikuya; Taku Mitome; Shinji Otake; Takashi Kawahara; Yusuke Ito; Kentaro Muraoka; Noboru Nakaigawa; Yayoi Kimura; Masaya Baba; Kiyotaka Nagahama; Hiroyuki Takahata; Ichiro Saito; Laura S Schmidt; W Marston Linehan; Tatsuhiko Kodama; Masahiro Yao; Nobuhiko Oridate; Hisashi Hasumi
Journal:  Biochem Biophys Res Commun       Date:  2019-12-02       Impact factor: 3.575

3.  Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma.

Authors:  A B Soares; P B Juliano; V C Araujo; K Metze; A Altemani
Journal:  Virchows Arch       Date:  2007-06-26       Impact factor: 4.064

4.  Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells.

Authors:  Laura Masuelli; Massimo Fantini; Monica Benvenuto; Pamela Sacchetti; Maria Gabriella Giganti; Ilaria Tresoldi; Paolo Lido; Florigio Lista; Federica Cavallo; Patrizia Nanni; Jeffrey Schlom; Andrea Modesti; Roberto Bei
Journal:  J Transl Med       Date:  2014-05-10       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.